Global Attenuated Vaccine for Human Rabies Production, Demand and Key Producers, 2022-2028
This report studies the global Attenuated Vaccine for Human Rabies production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Attenuated Vaccine for Human Rabies, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attenuated Vaccine for Human Rabies that contribute to its increasing demand across many markets.
The global Attenuated Vaccine for Human Rabies market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Attenuated Vaccine for Human Rabies total production and demand, 2017-2028, (K Units)
Global Attenuated Vaccine for Human Rabies total production value, 2017-2028, (USD Million)
Global Attenuated Vaccine for Human Rabies production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Attenuated Vaccine for Human Rabies consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Attenuated Vaccine for Human Rabies domestic production, consumption, key domestic manufacturers and share
Global Attenuated Vaccine for Human Rabies production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Attenuated Vaccine for Human Rabies production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Attenuated Vaccine for Human Rabies production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Attenuated Vaccine for Human Rabies market based on the following parameters – headquarters, production locations, products portfolio, Attenuated Vaccine for Human Rabies revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Attenuated Vaccine for Human Rabies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Attenuated Vaccine for Human Rabies Market, By Region:
1. How big is the global Attenuated Vaccine for Human Rabies market?
2. What is the demand of the global Attenuated Vaccine for Human Rabies market?
3. What is the year over year growth of the global Attenuated Vaccine for Human Rabies market?
4. What is the production and production value of the global Attenuated Vaccine for Human Rabies market?
5. Who are the key producers in the global Attenuated Vaccine for Human Rabies market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Attenuated Vaccine for Human Rabies, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attenuated Vaccine for Human Rabies that contribute to its increasing demand across many markets.
The global Attenuated Vaccine for Human Rabies market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Attenuated Vaccine for Human Rabies total production and demand, 2017-2028, (K Units)
Global Attenuated Vaccine for Human Rabies total production value, 2017-2028, (USD Million)
Global Attenuated Vaccine for Human Rabies production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Attenuated Vaccine for Human Rabies consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Attenuated Vaccine for Human Rabies domestic production, consumption, key domestic manufacturers and share
Global Attenuated Vaccine for Human Rabies production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Attenuated Vaccine for Human Rabies production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Attenuated Vaccine for Human Rabies production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Attenuated Vaccine for Human Rabies market based on the following parameters – headquarters, production locations, products portfolio, Attenuated Vaccine for Human Rabies revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Attenuated Vaccine for Human Rabies market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Attenuated Vaccine for Human Rabies Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Vero Cell
- Human Diploid Cell
- Hospital
- Clinic
- AstraZeneca
- GlaxoSmithKline
- Merck & Co Inc
- Sanofi Pasteur, Inc
- Cadila Pharmaceuticals Ltd
- Novartis AG
- Pfizer Inc
- Liaoning Yisheng Biopharmaceutical Co., Ltd
- Lanzhou Institute of Biological Products Co., Ltd
- Changchun Zhuoyi Biological Co., Ltd
- Guangzhou Nuocheng Biological Products Co., Ltd
- Ningbo Rongan Biopharmaceutical Co., Ltd
- Shandong Yidu Biotechnology Co., Ltd
- Chengdu Kanghua Biological Products Co., Ltd
- Wuhan Institute of Biological Products Co., Ltd
1. How big is the global Attenuated Vaccine for Human Rabies market?
2. What is the demand of the global Attenuated Vaccine for Human Rabies market?
3. What is the year over year growth of the global Attenuated Vaccine for Human Rabies market?
4. What is the production and production value of the global Attenuated Vaccine for Human Rabies market?
5. Who are the key producers in the global Attenuated Vaccine for Human Rabies market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Attenuated Vaccine for Human Rabies Introduction
1.2 World Attenuated Vaccine for Human Rabies Supply & Forecast
1.2.1 World Attenuated Vaccine for Human Rabies Production Value (2017 & 2021 & 2028)
1.2.2 World Attenuated Vaccine for Human Rabies Production (2017-2028)
1.2.3 World Attenuated Vaccine for Human Rabies Pricing Trends (2017-2028)
1.3 World Attenuated Vaccine for Human Rabies Production by Region
1.3.1 World Attenuated Vaccine for Human Rabies Production Value by Region (2017-2028)
1.3.2 World Attenuated Vaccine for Human Rabies Production by Region (2017-2028)
1.3.3 World Attenuated Vaccine for Human Rabies Average Price by Region (2017-2028)
1.3.4 North America Attenuated Vaccine for Human Rabies Production (2017-2028)
1.3.5 Europe Attenuated Vaccine for Human Rabies Production (2017-2028)
1.3.6 China Attenuated Vaccine for Human Rabies Production (2017-2028)
1.3.7 Japan Attenuated Vaccine for Human Rabies Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Attenuated Vaccine for Human Rabies Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Attenuated Vaccine for Human Rabies Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Attenuated Vaccine for Human Rabies Demand (2017-2028)
2.2 World Attenuated Vaccine for Human Rabies Consumption by Region
2.2.1 World Attenuated Vaccine for Human Rabies Consumption by Region (2017-2022)
2.2.2 World Attenuated Vaccine for Human Rabies Consumption Forecast by Region (2023-2028)
2.3 United States Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.4 China Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.5 Europe Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.6 Japan Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.7 South Korea Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.8 ASEAN Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.9 India Attenuated Vaccine for Human Rabies Consumption (2017-2028)
3 WORLD ATTENUATED VACCINE FOR HUMAN RABIES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Attenuated Vaccine for Human Rabies Production Value by Manufacturer (2017-2022)
3.2 World Attenuated Vaccine for Human Rabies Production by Manufacturer (2017-2022)
3.3 World Attenuated Vaccine for Human Rabies Average Price by Manufacturer (2017-2022)
3.4 Attenuated Vaccine for Human Rabies Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Attenuated Vaccine for Human Rabies Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Attenuated Vaccine for Human Rabies in 2021
3.5.3 Global Concentration Ratios (CR8) for Attenuated Vaccine for Human Rabies in 2021
3.6 Attenuated Vaccine for Human Rabies Market: Overall Company Footprint Analysis
3.6.1 Attenuated Vaccine for Human Rabies Market: Region Footprint
3.6.2 Attenuated Vaccine for Human Rabies Market: Company Product Type Footprint
3.6.3 Attenuated Vaccine for Human Rabies Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Attenuated Vaccine for Human Rabies Production Value Comparison
4.1.1 United States VS China: Attenuated Vaccine for Human Rabies Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Attenuated Vaccine for Human Rabies Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Attenuated Vaccine for Human Rabies Production Comparison
4.2.1 United States VS China: Attenuated Vaccine for Human Rabies Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Attenuated Vaccine for Human Rabies Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Attenuated Vaccine for Human Rabies Consumption Comparison
4.3.1 United States VS China: Attenuated Vaccine for Human Rabies Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Attenuated Vaccine for Human Rabies Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Attenuated Vaccine for Human Rabies Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Attenuated Vaccine for Human Rabies in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022)
4.5 China Attenuated Vaccine for Human Rabies Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Attenuated Vaccine for Human Rabies in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Attenuated Vaccine for Human Rabies Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Attenuated Vaccine for Human Rabies in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Attenuated Vaccine for Human Rabies Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Vero Cell
5.2.2 Human Diploid Cell
5.3 Market Segment by Type
5.3.1 World Attenuated Vaccine for Human Rabies Production by Type (2017-2028)
5.3.2 World Attenuated Vaccine for Human Rabies Production Value by Type (2017-2028)
5.3.3 World Attenuated Vaccine for Human Rabies Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Attenuated Vaccine for Human Rabies Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Attenuated Vaccine for Human Rabies Production by Application (2017-2028)
6.3.2 World Attenuated Vaccine for Human Rabies Production Value by Application (2017-2028)
6.3.3 World Attenuated Vaccine for Human Rabies Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Details
7.1.2 AstraZeneca Major Business
7.1.3 AstraZeneca Attenuated Vaccine for Human Rabies Product and Services
7.1.4 AstraZeneca Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 AstraZeneca Recent Developments/Updates
7.1.6 AstraZeneca Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Details
7.2.2 GlaxoSmithKline Major Business
7.2.3 GlaxoSmithKline Attenuated Vaccine for Human Rabies Product and Services
7.2.4 GlaxoSmithKline Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GlaxoSmithKline Recent Developments/Updates
7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.3 Merck & Co Inc
7.3.1 Merck & Co Inc Details
7.3.2 Merck & Co Inc Major Business
7.3.3 Merck & Co Inc Attenuated Vaccine for Human Rabies Product and Services
7.3.4 Merck & Co Inc Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Merck & Co Inc Recent Developments/Updates
7.3.6 Merck & Co Inc Competitive Strengths & Weaknesses
7.4 Sanofi Pasteur, Inc
7.4.1 Sanofi Pasteur, Inc Details
7.4.2 Sanofi Pasteur, Inc Major Business
7.4.3 Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Product and Services
7.4.4 Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Pasteur, Inc Recent Developments/Updates
7.4.6 Sanofi Pasteur, Inc Competitive Strengths & Weaknesses
7.5 Cadila Pharmaceuticals Ltd
7.5.1 Cadila Pharmaceuticals Ltd Details
7.5.2 Cadila Pharmaceuticals Ltd Major Business
7.5.3 Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Product and Services
7.5.4 Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Cadila Pharmaceuticals Ltd Recent Developments/Updates
7.5.6 Cadila Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Attenuated Vaccine for Human Rabies Product and Services
7.6.4 Novartis AG Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 Pfizer Inc
7.7.1 Pfizer Inc Details
7.7.2 Pfizer Inc Major Business
7.7.3 Pfizer Inc Attenuated Vaccine for Human Rabies Product and Services
7.7.4 Pfizer Inc Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Pfizer Inc Recent Developments/Updates
7.7.6 Pfizer Inc Competitive Strengths & Weaknesses
7.8 Liaoning Yisheng Biopharmaceutical Co., Ltd
7.8.1 Liaoning Yisheng Biopharmaceutical Co., Ltd Details
7.8.2 Liaoning Yisheng Biopharmaceutical Co., Ltd Major Business
7.8.3 Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.8.4 Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Liaoning Yisheng Biopharmaceutical Co., Ltd Recent Developments/Updates
7.8.6 Liaoning Yisheng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.9 Lanzhou Institute of Biological Products Co., Ltd
7.9.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.9.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.9.3 Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.9.4 Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.9.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.10 Changchun Zhuoyi Biological Co., Ltd
7.10.1 Changchun Zhuoyi Biological Co., Ltd Details
7.10.2 Changchun Zhuoyi Biological Co., Ltd Major Business
7.10.3 Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.10.4 Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Changchun Zhuoyi Biological Co., Ltd Recent Developments/Updates
7.10.6 Changchun Zhuoyi Biological Co., Ltd Competitive Strengths & Weaknesses
7.11 Guangzhou Nuocheng Biological Products Co., Ltd
7.11.1 Guangzhou Nuocheng Biological Products Co., Ltd Details
7.11.2 Guangzhou Nuocheng Biological Products Co., Ltd Major Business
7.11.3 Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.11.4 Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Guangzhou Nuocheng Biological Products Co., Ltd Recent Developments/Updates
7.11.6 Guangzhou Nuocheng Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.12 Ningbo Rongan Biopharmaceutical Co., Ltd
7.12.1 Ningbo Rongan Biopharmaceutical Co., Ltd Details
7.12.2 Ningbo Rongan Biopharmaceutical Co., Ltd Major Business
7.12.3 Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.12.4 Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Ningbo Rongan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Ningbo Rongan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Shandong Yidu Biotechnology Co., Ltd
7.13.1 Shandong Yidu Biotechnology Co., Ltd Details
7.13.2 Shandong Yidu Biotechnology Co., Ltd Major Business
7.13.3 Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.13.4 Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Shandong Yidu Biotechnology Co., Ltd Recent Developments/Updates
7.13.6 Shandong Yidu Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.14 Chengdu Kanghua Biological Products Co., Ltd
7.14.1 Chengdu Kanghua Biological Products Co., Ltd Details
7.14.2 Chengdu Kanghua Biological Products Co., Ltd Major Business
7.14.3 Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.14.4 Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
7.14.6 Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.15 Wuhan Institute of Biological Products Co., Ltd
7.15.1 Wuhan Institute of Biological Products Co., Ltd Details
7.15.2 Wuhan Institute of Biological Products Co., Ltd Major Business
7.15.3 Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.15.4 Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
7.15.6 Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Attenuated Vaccine for Human Rabies and Key Manufacturers
8.2 Attenuated Vaccine for Human Rabies Manufacturing Costs
8.3 Attenuated Vaccine for Human Rabies Production Process
8.4 Attenuated Vaccine for Human Rabies Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Attenuated Vaccine for Human Rabies Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Attenuated Vaccine for Human Rabies Typical Distributors
9.3 Attenuated Vaccine for Human Rabies Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Attenuated Vaccine for Human Rabies Introduction
1.2 World Attenuated Vaccine for Human Rabies Supply & Forecast
1.2.1 World Attenuated Vaccine for Human Rabies Production Value (2017 & 2021 & 2028)
1.2.2 World Attenuated Vaccine for Human Rabies Production (2017-2028)
1.2.3 World Attenuated Vaccine for Human Rabies Pricing Trends (2017-2028)
1.3 World Attenuated Vaccine for Human Rabies Production by Region
1.3.1 World Attenuated Vaccine for Human Rabies Production Value by Region (2017-2028)
1.3.2 World Attenuated Vaccine for Human Rabies Production by Region (2017-2028)
1.3.3 World Attenuated Vaccine for Human Rabies Average Price by Region (2017-2028)
1.3.4 North America Attenuated Vaccine for Human Rabies Production (2017-2028)
1.3.5 Europe Attenuated Vaccine for Human Rabies Production (2017-2028)
1.3.6 China Attenuated Vaccine for Human Rabies Production (2017-2028)
1.3.7 Japan Attenuated Vaccine for Human Rabies Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Attenuated Vaccine for Human Rabies Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Attenuated Vaccine for Human Rabies Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Attenuated Vaccine for Human Rabies Demand (2017-2028)
2.2 World Attenuated Vaccine for Human Rabies Consumption by Region
2.2.1 World Attenuated Vaccine for Human Rabies Consumption by Region (2017-2022)
2.2.2 World Attenuated Vaccine for Human Rabies Consumption Forecast by Region (2023-2028)
2.3 United States Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.4 China Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.5 Europe Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.6 Japan Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.7 South Korea Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.8 ASEAN Attenuated Vaccine for Human Rabies Consumption (2017-2028)
2.9 India Attenuated Vaccine for Human Rabies Consumption (2017-2028)
3 WORLD ATTENUATED VACCINE FOR HUMAN RABIES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Attenuated Vaccine for Human Rabies Production Value by Manufacturer (2017-2022)
3.2 World Attenuated Vaccine for Human Rabies Production by Manufacturer (2017-2022)
3.3 World Attenuated Vaccine for Human Rabies Average Price by Manufacturer (2017-2022)
3.4 Attenuated Vaccine for Human Rabies Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Attenuated Vaccine for Human Rabies Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Attenuated Vaccine for Human Rabies in 2021
3.5.3 Global Concentration Ratios (CR8) for Attenuated Vaccine for Human Rabies in 2021
3.6 Attenuated Vaccine for Human Rabies Market: Overall Company Footprint Analysis
3.6.1 Attenuated Vaccine for Human Rabies Market: Region Footprint
3.6.2 Attenuated Vaccine for Human Rabies Market: Company Product Type Footprint
3.6.3 Attenuated Vaccine for Human Rabies Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Attenuated Vaccine for Human Rabies Production Value Comparison
4.1.1 United States VS China: Attenuated Vaccine for Human Rabies Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Attenuated Vaccine for Human Rabies Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Attenuated Vaccine for Human Rabies Production Comparison
4.2.1 United States VS China: Attenuated Vaccine for Human Rabies Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Attenuated Vaccine for Human Rabies Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Attenuated Vaccine for Human Rabies Consumption Comparison
4.3.1 United States VS China: Attenuated Vaccine for Human Rabies Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Attenuated Vaccine for Human Rabies Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Attenuated Vaccine for Human Rabies Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Attenuated Vaccine for Human Rabies in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022)
4.5 China Attenuated Vaccine for Human Rabies Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Attenuated Vaccine for Human Rabies in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Attenuated Vaccine for Human Rabies Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Attenuated Vaccine for Human Rabies in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Attenuated Vaccine for Human Rabies Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Vero Cell
5.2.2 Human Diploid Cell
5.3 Market Segment by Type
5.3.1 World Attenuated Vaccine for Human Rabies Production by Type (2017-2028)
5.3.2 World Attenuated Vaccine for Human Rabies Production Value by Type (2017-2028)
5.3.3 World Attenuated Vaccine for Human Rabies Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Attenuated Vaccine for Human Rabies Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Attenuated Vaccine for Human Rabies Production by Application (2017-2028)
6.3.2 World Attenuated Vaccine for Human Rabies Production Value by Application (2017-2028)
6.3.3 World Attenuated Vaccine for Human Rabies Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 AstraZeneca
7.1.1 AstraZeneca Details
7.1.2 AstraZeneca Major Business
7.1.3 AstraZeneca Attenuated Vaccine for Human Rabies Product and Services
7.1.4 AstraZeneca Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 AstraZeneca Recent Developments/Updates
7.1.6 AstraZeneca Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Details
7.2.2 GlaxoSmithKline Major Business
7.2.3 GlaxoSmithKline Attenuated Vaccine for Human Rabies Product and Services
7.2.4 GlaxoSmithKline Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 GlaxoSmithKline Recent Developments/Updates
7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.3 Merck & Co Inc
7.3.1 Merck & Co Inc Details
7.3.2 Merck & Co Inc Major Business
7.3.3 Merck & Co Inc Attenuated Vaccine for Human Rabies Product and Services
7.3.4 Merck & Co Inc Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Merck & Co Inc Recent Developments/Updates
7.3.6 Merck & Co Inc Competitive Strengths & Weaknesses
7.4 Sanofi Pasteur, Inc
7.4.1 Sanofi Pasteur, Inc Details
7.4.2 Sanofi Pasteur, Inc Major Business
7.4.3 Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Product and Services
7.4.4 Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Pasteur, Inc Recent Developments/Updates
7.4.6 Sanofi Pasteur, Inc Competitive Strengths & Weaknesses
7.5 Cadila Pharmaceuticals Ltd
7.5.1 Cadila Pharmaceuticals Ltd Details
7.5.2 Cadila Pharmaceuticals Ltd Major Business
7.5.3 Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Product and Services
7.5.4 Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Cadila Pharmaceuticals Ltd Recent Developments/Updates
7.5.6 Cadila Pharmaceuticals Ltd Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Attenuated Vaccine for Human Rabies Product and Services
7.6.4 Novartis AG Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 Pfizer Inc
7.7.1 Pfizer Inc Details
7.7.2 Pfizer Inc Major Business
7.7.3 Pfizer Inc Attenuated Vaccine for Human Rabies Product and Services
7.7.4 Pfizer Inc Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Pfizer Inc Recent Developments/Updates
7.7.6 Pfizer Inc Competitive Strengths & Weaknesses
7.8 Liaoning Yisheng Biopharmaceutical Co., Ltd
7.8.1 Liaoning Yisheng Biopharmaceutical Co., Ltd Details
7.8.2 Liaoning Yisheng Biopharmaceutical Co., Ltd Major Business
7.8.3 Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.8.4 Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Liaoning Yisheng Biopharmaceutical Co., Ltd Recent Developments/Updates
7.8.6 Liaoning Yisheng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.9 Lanzhou Institute of Biological Products Co., Ltd
7.9.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.9.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.9.3 Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.9.4 Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.9.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.10 Changchun Zhuoyi Biological Co., Ltd
7.10.1 Changchun Zhuoyi Biological Co., Ltd Details
7.10.2 Changchun Zhuoyi Biological Co., Ltd Major Business
7.10.3 Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.10.4 Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Changchun Zhuoyi Biological Co., Ltd Recent Developments/Updates
7.10.6 Changchun Zhuoyi Biological Co., Ltd Competitive Strengths & Weaknesses
7.11 Guangzhou Nuocheng Biological Products Co., Ltd
7.11.1 Guangzhou Nuocheng Biological Products Co., Ltd Details
7.11.2 Guangzhou Nuocheng Biological Products Co., Ltd Major Business
7.11.3 Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.11.4 Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Guangzhou Nuocheng Biological Products Co., Ltd Recent Developments/Updates
7.11.6 Guangzhou Nuocheng Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.12 Ningbo Rongan Biopharmaceutical Co., Ltd
7.12.1 Ningbo Rongan Biopharmaceutical Co., Ltd Details
7.12.2 Ningbo Rongan Biopharmaceutical Co., Ltd Major Business
7.12.3 Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.12.4 Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Ningbo Rongan Biopharmaceutical Co., Ltd Recent Developments/Updates
7.12.6 Ningbo Rongan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
7.13 Shandong Yidu Biotechnology Co., Ltd
7.13.1 Shandong Yidu Biotechnology Co., Ltd Details
7.13.2 Shandong Yidu Biotechnology Co., Ltd Major Business
7.13.3 Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.13.4 Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Shandong Yidu Biotechnology Co., Ltd Recent Developments/Updates
7.13.6 Shandong Yidu Biotechnology Co., Ltd Competitive Strengths & Weaknesses
7.14 Chengdu Kanghua Biological Products Co., Ltd
7.14.1 Chengdu Kanghua Biological Products Co., Ltd Details
7.14.2 Chengdu Kanghua Biological Products Co., Ltd Major Business
7.14.3 Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.14.4 Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
7.14.6 Chengdu Kanghua Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.15 Wuhan Institute of Biological Products Co., Ltd
7.15.1 Wuhan Institute of Biological Products Co., Ltd Details
7.15.2 Wuhan Institute of Biological Products Co., Ltd Major Business
7.15.3 Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
7.15.4 Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
7.15.6 Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Attenuated Vaccine for Human Rabies and Key Manufacturers
8.2 Attenuated Vaccine for Human Rabies Manufacturing Costs
8.3 Attenuated Vaccine for Human Rabies Production Process
8.4 Attenuated Vaccine for Human Rabies Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Attenuated Vaccine for Human Rabies Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Attenuated Vaccine for Human Rabies Typical Distributors
9.3 Attenuated Vaccine for Human Rabies Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Attenuated Vaccine for Human Rabies Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Attenuated Vaccine for Human Rabies Production Value by Region (2017-2022) & (USD Million)
Table 3. World Attenuated Vaccine for Human Rabies Production Value by Region (2023-2028) & (USD Million)
Table 4. World Attenuated Vaccine for Human Rabies Production Value Market Share by Region (2017-2022)
Table 5. World Attenuated Vaccine for Human Rabies Production Value Market Share by Region (2023-2028)
Table 6. World Attenuated Vaccine for Human Rabies Production by Region (2017-2022) & (K Units)
Table 7. World Attenuated Vaccine for Human Rabies Production by Region (2023-2028) & (K Units)
Table 8. World Attenuated Vaccine for Human Rabies Production Market Share by Region (2017-2022)
Table 9. World Attenuated Vaccine for Human Rabies Production Market Share by Region (2023-2028)
Table 10. World Attenuated Vaccine for Human Rabies Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Attenuated Vaccine for Human Rabies Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Attenuated Vaccine for Human Rabies Major Market Trends
Table 13. World Attenuated Vaccine for Human Rabies Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Attenuated Vaccine for Human Rabies Consumption by Region (2017-2022) & (K Units)
Table 15. World Attenuated Vaccine for Human Rabies Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Attenuated Vaccine for Human Rabies Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Attenuated Vaccine for Human Rabies Producers in 2021
Table 18. World Attenuated Vaccine for Human Rabies Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Attenuated Vaccine for Human Rabies Producers in 2021
Table 20. World Attenuated Vaccine for Human Rabies Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Attenuated Vaccine for Human Rabies Company Evaluation Quadrant
Table 22. World Attenuated Vaccine for Human Rabies Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Attenuated Vaccine for Human Rabies Production Site of Key Manufacturer
Table 24. Attenuated Vaccine for Human Rabies Market: Company Product Type Footprint
Table 25. Attenuated Vaccine for Human Rabies Market: Company Product Application Footprint
Table 26. Attenuated Vaccine for Human Rabies Competitive Factors
Table 27. Attenuated Vaccine for Human Rabies New Entrant and Capacity Expansion Plans
Table 28. Attenuated Vaccine for Human Rabies Mergers & Acquisitions Activity
Table 29. United States VS China Attenuated Vaccine for Human Rabies Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Attenuated Vaccine for Human Rabies Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Attenuated Vaccine for Human Rabies Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Attenuated Vaccine for Human Rabies in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Attenuated Vaccine for Human Rabies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Attenuated Vaccine for Human Rabies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Attenuated Vaccine for Human Rabies in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Attenuated Vaccine for Human Rabies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Attenuated Vaccine for Human Rabies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Attenuated Vaccine for Human Rabies in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Attenuated Vaccine for Human Rabies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Attenuated Vaccine for Human Rabies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Attenuated Vaccine for Human Rabies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Attenuated Vaccine for Human Rabies Production by Type (2017-2022) & (K Units)
Table 49. World Attenuated Vaccine for Human Rabies Production by Type (2023-2028) & (K Units)
Table 50. World Attenuated Vaccine for Human Rabies Production Value by Type (2017-2022) & (USD Million)
Table 51. World Attenuated Vaccine for Human Rabies Production Value by Type (2023-2028) & (USD Million)
Table 52. World Attenuated Vaccine for Human Rabies Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Attenuated Vaccine for Human Rabies Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Attenuated Vaccine for Human Rabies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Attenuated Vaccine for Human Rabies Production by Application (2017-2022) & (K Units)
Table 56. World Attenuated Vaccine for Human Rabies Production by Application (2023-2028) & (K Units)
Table 57. World Attenuated Vaccine for Human Rabies Production Value by Application (2017-2022) & (USD Million)
Table 58. World Attenuated Vaccine for Human Rabies Production Value by Application (2023-2028) & (USD Million)
Table 59. World Attenuated Vaccine for Human Rabies Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Attenuated Vaccine for Human Rabies Average Price by Application (2023-2028) & (US$/Unit)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Major Business
Table 63. AstraZeneca Attenuated Vaccine for Human Rabies Product and Services
Table 64. AstraZeneca Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. AstraZeneca Recent Developments/Updates
Table 66. AstraZeneca Competitive Strengths & Weaknesses
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Major Business
Table 69. GlaxoSmithKline Attenuated Vaccine for Human Rabies Product and Services
Table 70. GlaxoSmithKline Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GlaxoSmithKline Recent Developments/Updates
Table 72. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 73. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 74. Merck & Co Inc Major Business
Table 75. Merck & Co Inc Attenuated Vaccine for Human Rabies Product and Services
Table 76. Merck & Co Inc Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Merck & Co Inc Recent Developments/Updates
Table 78. Merck & Co Inc Competitive Strengths & Weaknesses
Table 79. Sanofi Pasteur, Inc Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Pasteur, Inc Major Business
Table 81. Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Product and Services
Table 82. Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Pasteur, Inc Recent Developments/Updates
Table 84. Sanofi Pasteur, Inc Competitive Strengths & Weaknesses
Table 85. Cadila Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Cadila Pharmaceuticals Ltd Major Business
Table 87. Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 88. Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Cadila Pharmaceuticals Ltd Recent Developments/Updates
Table 90. Cadila Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 91. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 92. Novartis AG Major Business
Table 93. Novartis AG Attenuated Vaccine for Human Rabies Product and Services
Table 94. Novartis AG Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Novartis AG Recent Developments/Updates
Table 96. Novartis AG Competitive Strengths & Weaknesses
Table 97. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 98. Pfizer Inc Major Business
Table 99. Pfizer Inc Attenuated Vaccine for Human Rabies Product and Services
Table 100. Pfizer Inc Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Pfizer Inc Recent Developments/Updates
Table 102. Pfizer Inc Competitive Strengths & Weaknesses
Table 103. Liaoning Yisheng Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Liaoning Yisheng Biopharmaceutical Co., Ltd Major Business
Table 105. Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 106. Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Liaoning Yisheng Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Liaoning Yisheng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 109. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 111. Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 112. Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 114. Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 115. Changchun Zhuoyi Biological Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Changchun Zhuoyi Biological Co., Ltd Major Business
Table 117. Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 118. Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Changchun Zhuoyi Biological Co., Ltd Recent Developments/Updates
Table 120. Changchun Zhuoyi Biological Co., Ltd Competitive Strengths & Weaknesses
Table 121. Guangzhou Nuocheng Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Guangzhou Nuocheng Biological Products Co., Ltd Major Business
Table 123. Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 124. Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Guangzhou Nuocheng Biological Products Co., Ltd Recent Developments/Updates
Table 126. Guangzhou Nuocheng Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 127. Ningbo Rongan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Ningbo Rongan Biopharmaceutical Co., Ltd Major Business
Table 129. Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 130. Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Ningbo Rongan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 132. Ningbo Rongan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 133. Shandong Yidu Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Shandong Yidu Biotechnology Co., Ltd Major Business
Table 135. Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 136. Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Shandong Yidu Biotechnology Co., Ltd Recent Developments/Updates
Table 138. Shandong Yidu Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 139. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Chengdu Kanghua Biological Products Co., Ltd Major Business
Table 141. Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 142. Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 144. Wuhan Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 145. Wuhan Institute of Biological Products Co., Ltd Major Business
Table 146. Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 147. Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Attenuated Vaccine for Human Rabies Raw Material
Table 149. Key Manufacturers of Attenuated Vaccine for Human Rabies Raw Materials
Table 150. Attenuated Vaccine for Human Rabies Typical Distributors
Table 151. Attenuated Vaccine for Human Rabies Typical Customers
Table 1. World Attenuated Vaccine for Human Rabies Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Attenuated Vaccine for Human Rabies Production Value by Region (2017-2022) & (USD Million)
Table 3. World Attenuated Vaccine for Human Rabies Production Value by Region (2023-2028) & (USD Million)
Table 4. World Attenuated Vaccine for Human Rabies Production Value Market Share by Region (2017-2022)
Table 5. World Attenuated Vaccine for Human Rabies Production Value Market Share by Region (2023-2028)
Table 6. World Attenuated Vaccine for Human Rabies Production by Region (2017-2022) & (K Units)
Table 7. World Attenuated Vaccine for Human Rabies Production by Region (2023-2028) & (K Units)
Table 8. World Attenuated Vaccine for Human Rabies Production Market Share by Region (2017-2022)
Table 9. World Attenuated Vaccine for Human Rabies Production Market Share by Region (2023-2028)
Table 10. World Attenuated Vaccine for Human Rabies Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Attenuated Vaccine for Human Rabies Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Attenuated Vaccine for Human Rabies Major Market Trends
Table 13. World Attenuated Vaccine for Human Rabies Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Attenuated Vaccine for Human Rabies Consumption by Region (2017-2022) & (K Units)
Table 15. World Attenuated Vaccine for Human Rabies Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Attenuated Vaccine for Human Rabies Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Attenuated Vaccine for Human Rabies Producers in 2021
Table 18. World Attenuated Vaccine for Human Rabies Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Attenuated Vaccine for Human Rabies Producers in 2021
Table 20. World Attenuated Vaccine for Human Rabies Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Attenuated Vaccine for Human Rabies Company Evaluation Quadrant
Table 22. World Attenuated Vaccine for Human Rabies Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Attenuated Vaccine for Human Rabies Production Site of Key Manufacturer
Table 24. Attenuated Vaccine for Human Rabies Market: Company Product Type Footprint
Table 25. Attenuated Vaccine for Human Rabies Market: Company Product Application Footprint
Table 26. Attenuated Vaccine for Human Rabies Competitive Factors
Table 27. Attenuated Vaccine for Human Rabies New Entrant and Capacity Expansion Plans
Table 28. Attenuated Vaccine for Human Rabies Mergers & Acquisitions Activity
Table 29. United States VS China Attenuated Vaccine for Human Rabies Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Attenuated Vaccine for Human Rabies Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Attenuated Vaccine for Human Rabies Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Attenuated Vaccine for Human Rabies in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Attenuated Vaccine for Human Rabies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Attenuated Vaccine for Human Rabies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Attenuated Vaccine for Human Rabies in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Attenuated Vaccine for Human Rabies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Attenuated Vaccine for Human Rabies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Attenuated Vaccine for Human Rabies in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Attenuated Vaccine for Human Rabies Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Attenuated Vaccine for Human Rabies Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Attenuated Vaccine for Human Rabies Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Attenuated Vaccine for Human Rabies Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Attenuated Vaccine for Human Rabies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Attenuated Vaccine for Human Rabies Production by Type (2017-2022) & (K Units)
Table 49. World Attenuated Vaccine for Human Rabies Production by Type (2023-2028) & (K Units)
Table 50. World Attenuated Vaccine for Human Rabies Production Value by Type (2017-2022) & (USD Million)
Table 51. World Attenuated Vaccine for Human Rabies Production Value by Type (2023-2028) & (USD Million)
Table 52. World Attenuated Vaccine for Human Rabies Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Attenuated Vaccine for Human Rabies Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Attenuated Vaccine for Human Rabies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Attenuated Vaccine for Human Rabies Production by Application (2017-2022) & (K Units)
Table 56. World Attenuated Vaccine for Human Rabies Production by Application (2023-2028) & (K Units)
Table 57. World Attenuated Vaccine for Human Rabies Production Value by Application (2017-2022) & (USD Million)
Table 58. World Attenuated Vaccine for Human Rabies Production Value by Application (2023-2028) & (USD Million)
Table 59. World Attenuated Vaccine for Human Rabies Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Attenuated Vaccine for Human Rabies Average Price by Application (2023-2028) & (US$/Unit)
Table 61. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 62. AstraZeneca Major Business
Table 63. AstraZeneca Attenuated Vaccine for Human Rabies Product and Services
Table 64. AstraZeneca Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. AstraZeneca Recent Developments/Updates
Table 66. AstraZeneca Competitive Strengths & Weaknesses
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Major Business
Table 69. GlaxoSmithKline Attenuated Vaccine for Human Rabies Product and Services
Table 70. GlaxoSmithKline Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. GlaxoSmithKline Recent Developments/Updates
Table 72. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 73. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 74. Merck & Co Inc Major Business
Table 75. Merck & Co Inc Attenuated Vaccine for Human Rabies Product and Services
Table 76. Merck & Co Inc Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Merck & Co Inc Recent Developments/Updates
Table 78. Merck & Co Inc Competitive Strengths & Weaknesses
Table 79. Sanofi Pasteur, Inc Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Pasteur, Inc Major Business
Table 81. Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Product and Services
Table 82. Sanofi Pasteur, Inc Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Pasteur, Inc Recent Developments/Updates
Table 84. Sanofi Pasteur, Inc Competitive Strengths & Weaknesses
Table 85. Cadila Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Cadila Pharmaceuticals Ltd Major Business
Table 87. Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 88. Cadila Pharmaceuticals Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Cadila Pharmaceuticals Ltd Recent Developments/Updates
Table 90. Cadila Pharmaceuticals Ltd Competitive Strengths & Weaknesses
Table 91. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 92. Novartis AG Major Business
Table 93. Novartis AG Attenuated Vaccine for Human Rabies Product and Services
Table 94. Novartis AG Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Novartis AG Recent Developments/Updates
Table 96. Novartis AG Competitive Strengths & Weaknesses
Table 97. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 98. Pfizer Inc Major Business
Table 99. Pfizer Inc Attenuated Vaccine for Human Rabies Product and Services
Table 100. Pfizer Inc Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Pfizer Inc Recent Developments/Updates
Table 102. Pfizer Inc Competitive Strengths & Weaknesses
Table 103. Liaoning Yisheng Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Liaoning Yisheng Biopharmaceutical Co., Ltd Major Business
Table 105. Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 106. Liaoning Yisheng Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Liaoning Yisheng Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 108. Liaoning Yisheng Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 109. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 110. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 111. Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 112. Lanzhou Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 114. Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 115. Changchun Zhuoyi Biological Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 116. Changchun Zhuoyi Biological Co., Ltd Major Business
Table 117. Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 118. Changchun Zhuoyi Biological Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Changchun Zhuoyi Biological Co., Ltd Recent Developments/Updates
Table 120. Changchun Zhuoyi Biological Co., Ltd Competitive Strengths & Weaknesses
Table 121. Guangzhou Nuocheng Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Guangzhou Nuocheng Biological Products Co., Ltd Major Business
Table 123. Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 124. Guangzhou Nuocheng Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Guangzhou Nuocheng Biological Products Co., Ltd Recent Developments/Updates
Table 126. Guangzhou Nuocheng Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 127. Ningbo Rongan Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Ningbo Rongan Biopharmaceutical Co., Ltd Major Business
Table 129. Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 130. Ningbo Rongan Biopharmaceutical Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Ningbo Rongan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 132. Ningbo Rongan Biopharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 133. Shandong Yidu Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Shandong Yidu Biotechnology Co., Ltd Major Business
Table 135. Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 136. Shandong Yidu Biotechnology Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Shandong Yidu Biotechnology Co., Ltd Recent Developments/Updates
Table 138. Shandong Yidu Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 139. Chengdu Kanghua Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Chengdu Kanghua Biological Products Co., Ltd Major Business
Table 141. Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 142. Chengdu Kanghua Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 144. Wuhan Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 145. Wuhan Institute of Biological Products Co., Ltd Major Business
Table 146. Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Product and Services
Table 147. Wuhan Institute of Biological Products Co., Ltd Attenuated Vaccine for Human Rabies Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Attenuated Vaccine for Human Rabies Raw Material
Table 149. Key Manufacturers of Attenuated Vaccine for Human Rabies Raw Materials
Table 150. Attenuated Vaccine for Human Rabies Typical Distributors
Table 151. Attenuated Vaccine for Human Rabies Typical Customers
LIST OF FIGURES
Figure 1. Attenuated Vaccine for Human Rabies Picture
Figure 2. World Attenuated Vaccine for Human Rabies Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Attenuated Vaccine for Human Rabies Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 5. World Attenuated Vaccine for Human Rabies Average Price (2017-2028) & (US$/Unit)
Figure 6. World Attenuated Vaccine for Human Rabies Production Value Market Share by Region (2017-2028)
Figure 7. World Attenuated Vaccine for Human Rabies Production Market Share by Region (2017-2028)
Figure 8. North America Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 9. Europe Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 10. China Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 11. Japan Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 12. Attenuated Vaccine for Human Rabies Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Attenuated Vaccine for Human Rabies Demand (2017-2028) & (K Units)
Figure 15. World Attenuated Vaccine for Human Rabies Consumption Market Share by Region (2017-2028)
Figure 16. United States Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 17. China Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 18. Europe Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 19. Japan Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 20. South Korea Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 22. India Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Attenuated Vaccine for Human Rabies by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Attenuated Vaccine for Human Rabies Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Attenuated Vaccine for Human Rabies Markets in 2021
Figure 26. United States VS China: Attenuated Vaccine for Human Rabies Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Attenuated Vaccine for Human Rabies Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Attenuated Vaccine for Human Rabies Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Attenuated Vaccine for Human Rabies in United States
Figure 30. Key Producers and Market Share of Attenuated Vaccine for Human Rabies in China
Figure 31. Key Producers and Market Share of Attenuated Vaccine for Human Rabies in Rest of World
Figure 32. World Attenuated Vaccine for Human Rabies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Attenuated Vaccine for Human Rabies Production Value Market Share by Type in 2021
Figure 34. Vero Cell
Figure 35. Human Diploid Cell
Figure 36. World Attenuated Vaccine for Human Rabies Production Market Share by Type (2017-2028)
Figure 37. World Attenuated Vaccine for Human Rabies Production Value Market Share by Type (2017-2028)
Figure 38. World Attenuated Vaccine for Human Rabies Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Attenuated Vaccine for Human Rabies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Attenuated Vaccine for Human Rabies Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Attenuated Vaccine for Human Rabies Production Market Share by Application (2017-2028)
Figure 44. World Attenuated Vaccine for Human Rabies Production Value Market Share by Application (2017-2028)
Figure 45. World Attenuated Vaccine for Human Rabies Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Attenuated Vaccine for Human Rabies in 2021
Figure 47. Manufacturing Process Analysis of Attenuated Vaccine for Human Rabies
Figure 48. Attenuated Vaccine for Human Rabies Industrial Chain
Figure 49. Distribution Channel Breakdown for Attenuated Vaccine for Human Rabies Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Attenuated Vaccine for Human Rabies Picture
Figure 2. World Attenuated Vaccine for Human Rabies Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Attenuated Vaccine for Human Rabies Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 5. World Attenuated Vaccine for Human Rabies Average Price (2017-2028) & (US$/Unit)
Figure 6. World Attenuated Vaccine for Human Rabies Production Value Market Share by Region (2017-2028)
Figure 7. World Attenuated Vaccine for Human Rabies Production Market Share by Region (2017-2028)
Figure 8. North America Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 9. Europe Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 10. China Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 11. Japan Attenuated Vaccine for Human Rabies Production (2017-2028) & (K Units)
Figure 12. Attenuated Vaccine for Human Rabies Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Attenuated Vaccine for Human Rabies Demand (2017-2028) & (K Units)
Figure 15. World Attenuated Vaccine for Human Rabies Consumption Market Share by Region (2017-2028)
Figure 16. United States Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 17. China Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 18. Europe Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 19. Japan Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 20. South Korea Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 22. India Attenuated Vaccine for Human Rabies Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Attenuated Vaccine for Human Rabies by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Attenuated Vaccine for Human Rabies Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Attenuated Vaccine for Human Rabies Markets in 2021
Figure 26. United States VS China: Attenuated Vaccine for Human Rabies Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Attenuated Vaccine for Human Rabies Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Attenuated Vaccine for Human Rabies Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Attenuated Vaccine for Human Rabies in United States
Figure 30. Key Producers and Market Share of Attenuated Vaccine for Human Rabies in China
Figure 31. Key Producers and Market Share of Attenuated Vaccine for Human Rabies in Rest of World
Figure 32. World Attenuated Vaccine for Human Rabies Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Attenuated Vaccine for Human Rabies Production Value Market Share by Type in 2021
Figure 34. Vero Cell
Figure 35. Human Diploid Cell
Figure 36. World Attenuated Vaccine for Human Rabies Production Market Share by Type (2017-2028)
Figure 37. World Attenuated Vaccine for Human Rabies Production Value Market Share by Type (2017-2028)
Figure 38. World Attenuated Vaccine for Human Rabies Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Attenuated Vaccine for Human Rabies Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Attenuated Vaccine for Human Rabies Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Attenuated Vaccine for Human Rabies Production Market Share by Application (2017-2028)
Figure 44. World Attenuated Vaccine for Human Rabies Production Value Market Share by Application (2017-2028)
Figure 45. World Attenuated Vaccine for Human Rabies Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Attenuated Vaccine for Human Rabies in 2021
Figure 47. Manufacturing Process Analysis of Attenuated Vaccine for Human Rabies
Figure 48. Attenuated Vaccine for Human Rabies Industrial Chain
Figure 49. Distribution Channel Breakdown for Attenuated Vaccine for Human Rabies Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
